Lisata Therapeutics CEO discusses enrollment milestone for pancreatic cancer trial

Proactive: You've completed patient enrollment for the pancreatic cancer cohorts in your phase 1b/2a clinical trial. That's another milestone for the trial. This trial, conducted in conjunction with a university cancer center, allows us to see pre- and post-treatment biopsies of the tumors. This provides us with physiological and quantitative information regarding cytotoxic T cell infiltration of the tumors. It corroborates in humans what we've previously seen in animals and anecdotally in other studies – t ...